TWEAK与原发性高血压患者心脏重塑的相关性
[Abstract]:The study of hypertension is one of the most common cardiovascular system diseases, which has been paid more and more attention due to its high morbidity and young age in recent years. The changes of heart function in the early stage of hypertension were mainly characterized by the decrease of the relaxation function and the increase of the degree of stiffness of the myocardium. The long-term pressure load of high blood pressure, the structure and function of the cardiac muscle cell and the extracellular matrix are gradually changed, resulting in the enlargement of the left atrium, the left ventricular hypertrophy and the expansion of the heart remodeling, and finally leads to the adverse cardiovascular events such as arrhythmia, heart failure, sudden cardiac death, and the like. The tumor necrosis factor-like apoptosis inducing agent (TWEAK), as one of the members of the tumor necrosis factor superfamily, is a cross-membrane homologous trimer with a total length of 249 amino acids, and can be hydrolyzed into a soluble cytokine with a plurality of functions, The only clear TWEAK receptor is the fibroblast growth factor inducing early response protein 14 (Fn14), the binding of TWEAK to the Fn14 receptor mediates the biological processes including proliferation, migration, apoptosis, differentiation, angiogenesis and inflammation, and in the case of acute myocardial infarction, heart failure, It plays an important role in the pathophysiological process of cardiovascular system diseases such as hypertension. The increase of the matrix metalloproteinases (MMPs) in the heart tissue can accelerate the degradation of the extracellular matrix of the cardiac muscle cells, and after the degradation of the extracellular matrix, it prevents the effect of the excessive elongation of the cardiac muscle cells, and then the cardiac muscle cells are elongated, the ventricular wall is thin, the left ventricle is expanded, resulting in a significant decrease in the blood function of the heart pump. With the in-depth of the study of hypertension and the application of echocardiography in the clinical, the early heart remodeling caused by hypertension is becoming more and more important. The expression of TWEAK and sMMP-1 in peripheral venous blood of patients with essential hypertension was measured by echocardiography. The left atrial diameter (LAD), left atrial volume (LAV), left atrial volume index (LAVI), and early wave E of mitral flow were measured by echocardiography. Peak ratio E/ E of the peak of atrial contraction wave A, E/ A and the side wall of the mitral annulus in the mitral flow To study the relationship between the expression of TWEAK and the remodeling of hypertensive heart. Purpose 1. To investigate the expression of tumor necrosis factor-like apoptosis-inducing agent in essential hypertension and its relationship with heart remodeling in patients with essential hypertension. 88 patients with essential hypertension were selected as hypertension group, and the 50th percentile of serum TWEAK was divided into high expression group (n = 51) and low expression group (n = 37), and 20 cases of healthy physical examination in the same period were selected as control group. The expression of TWEAK and Fn14 mRNA in peripheral venous blood mononuclear cells (PBMCs) was detected by RT-PCR. The soluble TWEAK (sTWEAK), matrix metalloproteinase-1 (sMMP-1), hypersensitive C-reactive protein (hs-CRP) and fibroblast growth factor were detected by ELISA. Echocardiography was used to measure the peak value ratio E/ E 'of the longitudinal axis of the sternal long axis, the LAD, the LAV, the LAVI, the mitral flow, the early wave E, the mitral flow, the atrial contraction wave A, the E/ A and the side wall motion of the mitral annulus.. Results 1. The expression of TWEAK mRNA in the high-and low-expression groups was higher than that in the control group (P0.05), and the high-expression group was significantly higher than that of the low-expression group (P0.01). The expression of Fn14 mRNA was not statistically different among the groups. The levels of sTWEAK and sMMP-1 in the low expression group were higher than that in the control group (P = 0.02; P = 0.001), and sTWEAK and sMMP-1 were significantly higher in the high expression group than in the lower expression group (P = 0. 006; P 0.01). sFn14 levels were not statistically different between groups. high expression group and low expression group LAVI, E/ E The expression of TWEAK, TWEAK and sMMP-1, LAVI, E/ E' was higher than that in the control group (P0.05). There was a significant positive correlation between hs-CRP and hs-CRP (P0.01). Conclusion TWEAK is highly expressed in patients with high blood pressure; sMMP-1 is highly expressed in patients with high blood pressure; cardiac remodeling in patients with hypertension is related to high expression of TWEAK; TWEAK may be involved in the development of cardiac remodeling by inducing an up-regulation and inflammatory response of sMMP-1.
【学位授予单位】:山东大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R544.11
【相似文献】
相关期刊论文 前10条
1 张世联,王薇,朱文萍,胡晓东,赵睿珊;原发性高血压患者血浆甲状旁腺高血压因子的变化[J];临床心血管病杂志;2000年06期
2 李立明;原发性高血压研究方兴未艾、任重道远[J];中华流行病学杂志;2000年03期
3 李立明;中国原发性高血压社区防治的进展[J];中华流行病学杂志;2000年04期
4 钱海凌;原发性高血压防治新进展[J];广西中医学院学报;2000年01期
5 唐本兰,孟书;原发性高血压患者的个性分析及护理[J];川北医学院学报;2000年03期
6 樊敏;原发性高血压患者院外护理指导[J];齐鲁护理杂志;2000年05期
7 沓世念,雷真华;原发性高血压u波倒置42例临床分析[J];中国航天工业医药;2000年03期
8 孙红军,李英,李永军;光量子治疗原发性高血压患者钠钾ATP酶改变的实验研究[J];实用医技;2000年09期
9 朱瑞云;中青年原发性高血压患者血压控制不佳的原因分析[J];护士进修杂志;2001年12期
10 谢春雨,谢正,张强;原发性高血压患者多相人格检测的临床意义[J];河南实用神经疾病杂志;2001年04期
相关会议论文 前10条
1 常桂娟;李涛;李南方;;原发性高血压与高同型半胱氨酸血症的临床分析[A];中国微循环学会第五届中国微循环学术大会论文摘要汇编[C];2004年
2 常桂娟;李涛;李南方;;原发性高血压与高同型半胱氨酸血症的临床分析[A];中华医学会心血管病分会第八次全国心血管病学术会议汇编[C];2004年
3 张子波;杨康鹃;杜婷婷;全美燕;金雄吉;金元哲;;延边朝鲜族、汉族原发性高血压遗传流行病学研究[A];东北三省及内蒙古地区遗传学研究进展学术研讨会论文汇编[C];2009年
4 张子波;杨康鹃;金雄吉;金元哲;;延边地区原发性高血压遗传学研究[A];第八次全国医学遗传学学术会议(中华医学会2009年医学遗传学年会)论文摘要汇编[C];2009年
5 周鹏;陈刚;王博;张成;刘文敏;魏然;栾萌;杨树林;刘阳;高春义;;山东省原发性高血压2号染色体基因扫描研究[A];山东生物化学与分子生物学会2009年学术会议论文汇编[C];2009年
6 郭路通;;高血压病治疗探讨[A];2009年全国基层优秀中医表彰大会暨全国第二次民间验方、诊疗技术学术研讨会会议论文集[C];2009年
7 魏之星;王嵩;;肾小球滤过率在原发性高血压致肾功能损害中的诊断价值[A];第十次全国中西医结合影像学术研讨会暨全国中西医结合影像学研究与诊断学习班资料汇编[C];2009年
8 魏之星;王嵩;;肾小球滤过率在原发性高血压致肾功能损害中的诊断价值[A];第十一次全国中西医结合影像学术研讨会暨全国中西医结合影像学研究进展学习班资料汇编[C];2010年
9 薛凌;支邵册;卢中秋;孟燕子;王燕;陈红;邱俏檬;吕建新;管敏鑫;;携带线粒体4401 A>G突变的两个中国汉族母系遗传原发性高血压家系[A];遗传学与社会可持续发展——2010中国青年遗传学家论坛论文摘要汇编[C];2010年
10 何芳;邓峰美;钟华;杨建峰;石晓鹏;王刚;王振焕;陈雄英;;转化生长因子β_1基因标签单核苷酸多态性与新疆汉族原发性高血压相关性研究[A];中国病理生理学会第九届全国代表大会及学术会议论文摘要[C];2010年
相关重要报纸文章 前10条
1 李天舒;原发性高血压具有母系遗传特点[N];健康报;2007年
2 陈栋琳;治原发性高血压单方[N];民族医药报;2004年
3 夏勇江;针刺治疗原发性高血压疗效观察[N];农村医药报(汉);2006年
4 陈康远;六味地黄汤加味治疗原发性高血压[N];中国医药报;2004年
5 阜外心血管病医院;给原发性高血压患者三个锦囊[N];保健时报;2008年
6 内蒙古 元登;蒙医药治疗原发性高血压[N];民族医药报;2002年
7 ;母子降压汤治疗原发性高血压[N];中国中医药报;2003年
8 ;平肝潜阳针法对原发性高血压患者甲襞微循环的影响[N];中国中医药报;2005年
9 肖云翔;明珠之花在高原绽放[N];云南科技报;2007年
10 赵秀君;中西药合用治疗顽固性原发性高血压[N];中国医药报;2005年
相关博士学位论文 前10条
1 李涓;辨证循经取穴治疗原发性高血压的临床疗效评价研究[D];成都中医药大学;2015年
2 曾俊义;循环miRNA及miR-31对原发性高血压左室肥厚的影响[D];南昌大学;2016年
3 方正旭;ET-1、eNOS基因多态性与江西汉族人群原发性高血压及硝苯地平降压疗效的相关性研究[D];南昌大学;2016年
4 王述琦;原发性高血压患者11β-类固醇脱氢酶2启动子区甲基化与血浆肾素的关系[D];青岛大学;2016年
5 孙蓓;藏族原发性高血压的分子遗传学研究[D];中国协和医科大学;2004年
6 刘永生;内皮型一氧化氮合酶基因多态性与原发性高血压发病相关性的研究[D];吉林大学;2014年
7 牛文全;原发性高血压易感基因多位点间相互作用的数学计算模型[D];中国协和医科大学;2008年
8 王志敏;过氧化氢酶基因多态性在原发性高血压中的作用与分子机制研究[D];复旦大学;2006年
9 孔祥东;肾素—血管紧张素系统基因多态性与原发性高血压[D];四川大学;2003年
10 王玉;中国原发性高血压伴高同型半胱氨酸血症遗传环境危险因素分析[D];中国人民解放军军医进修学院;2012年
相关硕士学位论文 前10条
1 董天崴;白介素-7与原发性高血压及血管内皮生长因子的相关性研究[D];佳木斯大学;2008年
2 刘霞;胰岛素样生长因子-I与原发性高血压的研究[D];山西医科大学;2005年
3 周莺;社区原发性高血压患者心理社会因素调查[D];浙江大学;2007年
4 冯文霄;相近遗传条件下原发性高血压患者的危险因素研究[D];中国医科大学;2007年
5 张美玉;通脉颗粒对原发性高血压气虚血瘀证患者动脉僵硬度的干预研究[D];福建中医药大学;2015年
6 张泽凡;速度向量成像技术评价原发性高血压患者腹主动脉力学运动状态[D];内蒙古大学;2015年
7 谭宇;MAP2K3/p38信号通路在原发性高血压中的机制研究[D];北京协和医学院;2015年
8 韩雄毅;延边地区人群NPPA基因多态性与原发性高血压易感性相关研究[D];延边大学;2015年
9 张文雯;新疆哈、汉族人群原发性高血压与缝隙连接基因多态性的相关性研究[D];石河子大学;2015年
10 郑丽华;新疆维吾尔族、蒙古族原发性高血压患者血清亲环素A的表达及意义研究[D];石河子大学;2015年
,本文编号:2378713
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2378713.html